Search

Your search keyword '"Köhler BC"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Köhler BC" Remove constraint Author: "Köhler BC" Database MEDLINE Remove constraint Database: MEDLINE
23 results on '"Köhler BC"'

Search Results

1. Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.

2. Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood.

3. Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC.

4. Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.

5. Bcl-x L as prognostic marker and potential therapeutic target in cholangiocarcinoma.

6. Gene expression-based prediction of pazopanib efficacy in sarcoma.

7. Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors.

8. MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.

9. Caspase-8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in mice.

10. Comprehensive proteomic profiling of serum extracellular vesicles in patients with colorectal liver metastases identifies a signature for non-invasive risk stratification and early-response evaluation.

11. STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma.

12. Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome.

13. The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma.

14. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.

15. Completion rate and impact on physician-patient relationship of video consultations in medical oncology: a randomised controlled open-label trial.

16. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

17. Knockdown of Atg7 Induces Nuclear-LC3 Dependent Apoptosis and Augments Chemotherapy in Colorectal Cancer Cells.

18. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.

19. An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy.

20. Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancy.

21. Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions.

22. Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines.

23. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.

Catalog

Books, media, physical & digital resources